Literature DB >> 19773395

A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index.

Annamaria Colao1, Carolina Di Somma, Silvia Savastano, Francesca Rota, Maria Cristina Savanelli, Gianluca Aimaretti, Gaetano Lombardi.   

Abstract

OBJECTIVE: The objective of the study was to reevaluate the diagnostic accuracy of GH peak after GHRH plus arginine test (GHRH+ARG) according to patients' age, body mass index (BMI), and waist circumference to diagnose GH deficiency (GHD). OUTCOME MEASURES: GH peak after GHRH+ARG and IGF-I levels reported as sd score.
SUBJECTS: Subjects included 408 controls (218 women, 190 men, aged 15-80 yr) and 374 patients with hypopituitarism (167 women, 207 men, aged 16-83 yr).
RESULTS: In the (elderly) healthy subjects 15-25 yr old (young), 26-65 yr old (adults) and older than 65 yr, GH cutoffs were 15.6, 11.7, and 8.5 microg/liter, 11.8, 8.1, and 5.5 microg/liter, and 9.2, 6.1, and 4.0 microg/liter, respectively, in the lean, overweight, and obese subjects. Waist circumference was the best predictor of GH peak (t = -7.6, P < 0.0001) followed by BMI (t = -6.7, P < 0.0001) and age (t = -5.7, P < 0.0001). Based on the old (<9.1 microg/liter) and new GH cutoff, 286 (76.5%) and 276 (73.8%) of 374 hypopituitary patients had severe GHD. The receiving-operator characteristic analysis showed GH cutoffs in line with the third percentile or slightly higher results so that the prevalence of GHD increased to 90.1%.
CONCLUSIONS: The results of the current study show that waist circumference and BMI are the strongest predictors of GH peak after GHRH+ARG followed by age. However, the old cutoff value of 9.0 microg/liter was in line with the new cutoffs in 95% of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773395     DOI: 10.1210/jc.2009-1134

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Growth hormone treatment in adults with growth hormone deficiency: the transition.

Authors:  M E Molitch
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Diagnosis: a reappraisal of the diagnosis of growth hormone deficiency.

Authors:  Gudmundur Johannsson
Journal:  Nat Rev Endocrinol       Date:  2010-04       Impact factor: 43.330

Review 3.  Idiopathic adult growth hormone deficiency.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

4.  Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Authors:  Kevin C J Yuen; Beverly M K Biller; Laurence Katznelson; Sharon A Rhoads; Michelle H Gurel; Olivia Chu; Valentina Corazzini; Kellie Spiller; Murray B Gordon; Roberto Salvatori; David M Cook
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

5.  Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

Authors:  Maria Cristina Savanelli; Elisabetta Scarano; Giovanna Muscogiuri; Luigi Barrea; Laura Vuolo; Manila Rubino; Silvia Savastano; Annamaria Colao; Carolina Di Somma
Journal:  Endocrine       Date:  2015-10-29       Impact factor: 3.633

6.  Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index.

Authors:  Carolina Di Somma; Alessandro Ciresi; Marco C Amato; Silvia Savastano; Maria Cristina Savanelli; Elisabetta Scarano; Annamaria Colao; Carla Giordano
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

7.  The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.

Authors:  Alessandro Ciresi; Stefano Radellini; Valentina Guarnotta; Carla Giordano
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

Review 8.  Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS).

Authors:  Ioannis Karamouzis; Loredana Pagano; Flavia Prodam; Chiara Mele; Marco Zavattaro; Arianna Busti; Paolo Marzullo; Gianluca Aimaretti
Journal:  Endocrine       Date:  2015-11-16       Impact factor: 3.633

9.  Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.

Authors:  Laura E Dichtel; Kevin C J Yuen; Miriam A Bredella; Anu V Gerweck; Brian M Russell; Ariana D Riccio; Michelle H Gurel; Patrick M Sluss; Beverly M K Biller; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 10.  Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2018-02-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.